Acadia Healthcare Co Stock (NASDAQ: ACHC)

Acadia Healthcare Co Stock (NASDAQ:ACHC), Trade Ideas

Acadia Healthcare Co

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

Aachen,,Germany,September,2019:,Uber,Driver,Holding,His,Smartphone,In

Equities

News

Markets

Movers

General

ACHC

MILN

UBER

Uber Technologies shares edge higher following its partnership with The Vitamin Shoppe and collaborations aimed at enhancing access to behavioral healthcare and expanding freight management in Europe.

What&#39;s Going On With Uber Technologies Shares Friday?

Uber

Large Cap

iShares Dow Jones Transportation Average Index Fund

TPOR

Uber Health and Acadia Healthcare join forces to provide seamless transportation for behavioral health and addiction treatment. With a focus on Acadia&#39;s Comprehensive Treatment Centers network, patients can swiftly access life-saving medication-assisted treatment for opioid addiction. 

Breaking Barriers: Uber Health And Acadia Healthcare Partner To Enhance Behavioral Health Access

Penny Stocks

Small Cap

Pre-Market Outlook

Trading Ideas

COHR

RDFN

SILK

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Silk Road Medical, Acadia Healthcare And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

Acadia Healthcare Company, Inc. - Common Stock

Acadia Healthcare Co Inc

Deutsche Bank analyst Pito Chickering upgrades Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) from Sell to Hold and maintains $70 price target.

Upgrades

Price Target

Analyst Ratings

Deutsche Bank Upgrades Acadia Healthcare Co to Hold, Maintains $70 Price Target

Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) shares are trading <a href="https://www.benzinga.com/premarket" target="_blank" rel="noreferrer noopener">higher in the morning session on Friday.</a>
Yesterday, the company entered into a new nationwide partnership with&nbsp;The Vitamin Shoppe, bringing the New Jersey-based health and wellness retailer&#8217;s selection to the Uber Eats app.
About 700 locations of The Vitamin Shoppe and Super Supplements are now available for ordering on Uber Eats across the U.S.
Read More:<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38091557/health-on-demand-uber-eats-partners-with-the-vitamin-shoppe" rel="noreferrer noopener">&nbsp;Health On Demand: Uber Eats Partners With The Vitamin Shoppe</a>
Earlier this month, Uber Health collaborated with Acadia Healthcare Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) to improve access to life-saving behavioral health care and addiction treatment.
The companies will initially focus on Acadia&#8217;s national Comprehensive Treatment Centers (CTCs) network, which will provide medication-assisted treatment (MAT) in combination with counseling and behavioral therapies for those struggling with opioid addiction.&nbsp;
The collaboration will provide patients with transportation to begin treatment quickly and efficiently. Acadia and Uber Health plan to roll out the program to 19 facilities across several states.
Related:<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38071488/breaking-barriers-uber-health-and-acadia-healthcare-partner-to-enhance-behavioral-health-access" rel="noreferrer noopener">&nbsp;Breaking Barriers: Uber Health And Acadia Healthcare Partner To Enhance Behavioral Health Access</a>
Last month, the company&#8217;s smaller segment&nbsp;Uber Freight&nbsp;was in the headlines for aggressively pursuing growth in Europe&#8217;s diverse logistics sector, targeting a tenfold increase in its freight management to 2 billion euros by 2028 through a comprehensive digital platform that oversees companies&#8217; entire supply chains.&nbsp;
Check This Out:&nbsp;<a target="_blank" href="https://www.benzinga.com/government/24/03/37624971/uber-freight-targets-european-market-for-10x-expansion-push-by-2028" rel="noreferrer noopener">Uber Freight Targets European Market For 10X Expansion Push By 2028</a>
In February, Uber reported fourth-quarter fiscal 2023 revenue growth of 15% year-on-year to $9.94 billion,&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/02/37130853/ubers-stock-is-on-a-ride-wednesday-heres-why" rel="noreferrer noopener">beating the consensus of $9.76 billion.&nbsp;</a>
Uber&#8217;s GAAP EPS of 29 cents beat the consensus of 17 cents. Trips grew 24% year-over-year to 2.60 billion, equivalent to 28 million per day.&nbsp;
Investors can gain exposure to Uber via&nbsp;First Trust US Equity Opportunities ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FPX#NYSE">FPX</a>) and&nbsp;Global X Millennial Consumer ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MILN#NASDAQ">MILN</a>).
Price Action:&nbsp;UBER shares are trading higher by 2.369% to $76.69 on the last check Friday.&nbsp;
Photo via Shutterstock

What's Going On With Uber Technologies Shares Friday?

On Tuesday,&nbsp;Uber Technologies, Inc.&#8216;s&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) Uber Health collaborated with&nbsp;Acadia Healthcare Company, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) to improve access to life-saving behavioral&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/b38046297/acadia-healthcare-accelerates-access-to-care-with-uber-health" rel="noreferrer noopener">health care and addiction treatment</a>.
The companies will initially focus on Acadia&#8217;s national Comprehensive Treatment Centers (CTCs) network, which will provide medication-assisted treatment (MAT) in combination with counseling and behavioral therapies for those struggling with opioid addiction.&nbsp;
The collaboration will provide patients with transportation to begin treatment quickly and efficiently. Acadia and Uber Health plan to roll out the program to 19 facilities across several states.
Caitlin Donovan, Global Head of Uber Health, said, &#8220;Behavioral healthcare services are critical for many patients struggling with addiction; lack of transportation shouldn&#8217;t stand in the way of accessing this support.&#8221;&nbsp;
&#8220;By joining forces with Uber Health, Acadia Healthcare can quickly and easily connect patients with transportation to get the care they need, when they need it—and ultimately help improve patient outcomes at scale.&#8221;
Dr. Nasser Khan, Group President, Acadia Healthcare CTC, said, &#8220;Working with Uber Health allows Acadia to eliminate this barrier and, in turn, shorten the length of time patients need to wait to begin life-saving treatment. In addition, the collaboration removes financial barriers to transportation access which can be a major roadblock to success in treatment.&#8221;
Investors can gain exposure to the stock via&nbsp;IShares Trust IShares U.S. Transportation ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/IYT#BATS">IYT</a>) and&nbsp;Direxion Daily Transportation Bull 3X Shares&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPOR#NYSE">TPOR</a>).
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/03/37775562/uber-shifts-gears-down-under-reportedly-lands-178m-settlement-with-australian-taxi-drivers" rel="noreferrer noopener">Uber Shifts Gears Down Under: Reportedly Lands $178M Settlement with Australian Taxi Drivers</a>
Price Action: UBER shares are up 1.69% at $78.28 on the last check Wednesday.
Photo via Shutterstock

Acadia Healthcare Acquires Three Comprehensive Treatment Centers In North Carolina; Financial Terms Not Disclosed

ARCH

CORRECTION: Ticker for Acadia Healthcare Is ACHC

Mizuho analyst Ann Hynes maintains Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) with a Neutral and raises the price target from $77 to $84.

Mizuho Maintains Neutral on Acadia Healthcare Co, Raises Price Target to $84

Barclays analyst Andrew Mok initiates coverage on Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) with a Overweight rating and announces Price Target of $100.

Initiation

Barclays Initiates Coverage On Acadia Healthcare Co with Overweight Rating, Announces Price Target of $100

Cantor Fitzgerald analyst Sarah James reiterates Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) with a Neutral and maintains $90 price target.

Reiteration

Cantor Fitzgerald Reiterates Neutral on Acadia Healthcare Co, Maintains $90 Price Target

In the latest quarter, 4 analysts provided ratings for Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $97.25, along with a high estimate of $102.00 and a low estimate of $92.00. Witnessing a positive shift, the current average has risen by 11.78% from the previous average price target of $87.00.
<img src="https://www.benzinga.com/files/images/story/2024/1709571628_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Acadia Healthcare Co by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$94.00</td>
<td>-</td>
</tr>
<tr>
<td>Gary Taylor</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Outperform</td>
<td>$101.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$102.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Scott Fidel</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$92.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Acadia Healthcare Co. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Acadia Healthcare Co compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Acadia Healthcare Co's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Acadia Healthcare Co's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ACHC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Acadia Healthcare Co analyst ratings.</a>
<h2>Delving into Acadia Healthcare Co's Background</h2>
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
<h3>Breaking Down Acadia Healthcare Co's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Negative Revenue Trend: Examining Acadia Healthcare Co's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -1.0% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Acadia Healthcare Co's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 7.77%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Acadia Healthcare Co's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.1%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Acadia Healthcare Co's ROA stands out, surpassing industry averages. With an impressive ROA of 1.08%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Acadia Healthcare Co's debt-to-equity ratio is below the industry average at 0.54, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Acadia Healthcare Co Through 4 Analysts

RBC Capital analyst Ben Hendrix reiterates Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) with a Outperform and maintains $94 price target.

RBC Capital Reiterates Outperform on Acadia Healthcare Co, Maintains $94 Price Target

TD Cowen analyst Gary Taylor maintains Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) with a Outperform and raises the price target from $86 to $101.

TD Cowen Maintains Outperform on Acadia Healthcare Co, Raises Price Target to $101

UBS analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) with a Buy and raises the price target from $88 to $102.

UBS Maintains Buy on Acadia Healthcare Co, Raises Price Target to $102

Guidance

Acadia Healthcare Sees Q1 2024 Adj. EPS $0.78-$0.83 Vs $0.81 Est.; Revenue $775M-$785M Vs $770.472M Est.

Acadia Healthcare Sees FY24 Adj. ESP $3.40-$3.70 Vs $3.70 Est.; Revenue $3.18B-$3.25B Vs $3.215B Est.

Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Acadia Healthcare Co beat estimated earnings by 10.0%, reporting an EPS of $0.87 versus an estimate of $0.79.
Revenue was up $67.50 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.02 which was followed by a 1.0% drop in the share price the next day.
Here's a look at Acadia Healthcare Co's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.89</td>
<td>0.86</td>
<td>0.71</td>
<td>0.75</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.91</td>
<td>0.92</td>
<td>0.75</td>
<td>0.74</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>725.31M</td>
<td>711.71M</td>
<td>691.44M</td>
<td>660.42M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>750.33M</td>
<td>731.34M</td>
<td>704.27M</td>
<td>675.29M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Acadia Healthcare Co <a href="https://www.benzinga.com/quote/ACHC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Recap: Acadia Healthcare Co Q4 Earnings

Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.79 by 7.59 percent. The company reported quarterly sales of $742.80 million which beat the analyst consensus estimate of $727.60 million by 2.09 percent. This is a 10.00 percent increase over sales of $675.29 million the same period last year.

Earnings Beats

Acadia Healthcare Co Q4 2023 Adj EPS $0.85 Beats $0.79 Estimate, Sales $742.80M Beat $727.60M Estimate

ACAD

AESI

AHCO

AIRS

ALEC

ALHC

AMBA

AMBC

APLS

ARKO

ARQT

ARRY

ATEC

AXON

BCSF

BECN

BGFV

BMBL

BWXT

BYND

CAVA

CBRL

CIVI

CLDT

CLNE

CLVT

CMLS

COMP

CPNG

CRDO

CYTK

EBAY

EHTH

ESPR

FARO

FLYW

FOUR

FSLR

FULC

GDOT

GLPI

GMRE

GSX Techedu Inc. American Depositary Shares

GOTU

GPOR

HRZN

HSIC

HURN

ICCC

ICFI

ICUI

IMAX

IMXI

INGN

INSE

IPAR

JAMF

KIND

KURA

KVYO

LAZR

LGND

LGVN

Earnings Scheduled For February 27, 2024

Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) has outperformed the market over the past 5 years by 12.16% on an annualized basis producing an average annual return of 24.92%. Currently, Acadia Healthcare Co has a market capitalization of $7.40 billion. 
Buying $100 In ACHC: If an investor had bought $100 of ACHC stock 5 years ago, it would be worth $290.84 today based on a price of $80.30 for ACHC at the time of writing.
<h3>Acadia Healthcare Co's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1707141614_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

Acadia Healthcare Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) today announced that it has formed a joint venture partnership with Ascension Seton, one of the leading, integrated healthcare systems in Austin, Texas, and a part of the Ascension national health network. The partnership will expand access to behavioral healthcare in Austin and surrounding communities.
The joint venture will focus on expanding Acadia's current operations at Cross Creek Hospital, as well as the number of inpatient behavioral beds available in Austin. Acadia will construct a 106-bed expansion of the acute behavioral hospital, increasing the total licensed bed count to 196 upon completion. Slated to open in late 2024, the new hospital will be named "Cross Creek Hospital together with Ascension Seton."
The joint venture hospital will be in close proximity to Ascension Seton hospitals and will be one of the training sites for students, residents and fellows from Dell Medical School at The University of Texas at Austin.
This is Acadia's second joint venture partnership with Ascension, having developed and opened Ascension Saint Thomas Behavioral Health Hospital in Nashville, Tennessee, in 2020. Ascension Seton selected Acadia as their joint venture partner in Austin because of Acadia's shared commitment to high-quality, compassionate, mission-driven care to improve the health of the individuals and communities they serve. Ascension Seton's decision was further solidified by Acadia's proven track record in joint venture partnerships and the existing relationship with the health system.
"We are proud to expand our strong working relationship with Ascension," said Chris Hunter, chief executive officer of Acadia Healthcare. "Through this joint venture, our organizations will partner in the delivery of high-quality behavioral healthcare to promote health and healing in the Austin community. With this announcement, Acadia now has 21 joint venture partnerships with premier health systems. We will continue this successful strategy to expand access to behavioral healthcare across the United States.
"This hospital will be a tremendous resource for those living in our community, including those who are most vulnerable, and we're thrilled to bring together the expertise and capabilities from our two great organizations," said Andy Davis, president and chief executive officer of Ascension Texas. "Acadia has an established track record of expanding access to high-quality, compassionate care in communities across the country. This joint venture will build upon our expertise while increasing the number of behavioral health beds and other behavioral health services available to patients throughout the region."

Biotech

Acadia Healthcare Enters Into A Joint Venture Partnership With Ascension Seton To Expand Behavioral Health Services In Austin, Texas

Stephens &amp; Co. analyst Scott Fidel upgrades Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) from Equal-Weight to Overweight and announces $92 price target.

Stephens & Co. Upgrades Acadia Healthcare Co to Overweight, Announces $92 Price Target

Acadia Healthcare Company, Inc. (ACHC) Q4 2023 Earnings Call Transcript

In a report released on February 27, Whit Mayo from Leerink Partners reiterated a Buy rating on Acadia Healthcare (ACHC – Research Report), with a ...

Buy Rating Affirmed: Acadia Healthcare's Strong Q4 Performance and Positive 2024 Outlook

RBC Capital analyst Ben Hendrix maintained a Buy rating on Acadia Healthcare (ACHC – Research Report) yesterday and set a price target of $94.00. T...

RBC Capital Reaffirms Their Buy Rating on Acadia Healthcare (ACHC)

Moody's cites credit impact to U.S. providers from UnitedHealth cyberattack

Moody's cites credit impact on U.S. providers from UnitedHealth cyberattack

Acadia Healthcare completes acquisitions of three treatment centers

Acadia Healthcare appoints Stephanie Eken as its new chief medical officer

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on 4D Molecular Therapeutics (FDMT – Research Report), ...

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Acadia Healthcare (ACHC) and Coherus Biosciences (CHRS)

Small and midcap pair trades for every sector - Oppenheimer

In a report released today, Pito Chickering from Deutsche Bank upgraded Acadia Healthcare (ACHC – Research Report) to a Hold, with a price target o...

Hold Rating on Acadia Healthcare Amid Legislative Uncertainties and Mixed Financial Outlook

AMSF

ATEN

CELH

CHRS

ESTC

EVER

FDMT

FTDR

HWKN

INSP

LFST

NBIX

OLLI

OTTR

PARR

PECO

PETQ

SAIA

SCHL

SGRY

SPMD

TBLA

USNA

VMEO

Press Releases

Acadia Healthcare Reports Fourth Quarter 2023 Results

Acadia Healthcare to Participate in Raymond James 45th Annual Institutional Investors Conference

Acadia Healthcare to Participate in the Barclays 26th Annual Global Healthcare Conference

Tufts Medicine and Acadia Healthcare Break Ground on New Behavioral Health Hospital to Serve the Greater Boston Area

Acadia Healthcare Acquires Three Comprehensive Treatment Centers in North Carolina

Investigation Alert Acadia Healthcare, Virtu Financial, Baxter International, and Hawaiian Electric: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below